Scientific Seminars 2025

app store

Agenda

Joint Session Hemostasis & Autoimmunity - October 14th

16th Hemostasis Advanced Seminar - October 14th-15th

12th International Autoimmunity Seminar - October 14th-15th

6th EEMEA Acute Care Experts Meeting - October 15th-16th

1st HLA & Immunogenetics Seminar - October 16th-17th

1st Transfusion Seminar - October 16th-17th

Event Pictures

Click here for "EEMEA Scientific Seminars 2025" Pictures

Joint Session

Novel APS Biomarkers

Patient Perspective on Surviving Thrombotic Events

The probable role of the likelihood ratio approach in diagnosing/classification of APS

How do we manage APS patients when the aPL profile turns negative?

New developments in the classification of the APS

Hemostasis Advanced Seminar

Accreditation and the Haemostasis Lab

Cybersecurity in Healthcare Institutions and the Laboratory

Innovation in Internal & External Quality Control: The Bayesian Concept

Factor XI: A new target for anticoagulation?

Contraception and Venous Thromboembolism

Application of Bayesian for QC Management in a Hemostasis Laboratory

Hemophilia treatments and the role of the lab

Challenges in the diagnosis of heparin-induced thrombocytopenia

Gene Therapy and Laboratory Monitoring in Haemophilia

Measurement Uncertainty and the Haemostasis Lab

FXIII and Post Partum Hemorrhage

Cancer-associated thrombosis: coagulation factors in cancer progression

International Autoimmunity Seminar

Inflammatory Rheumatic Diseases in Lithuania: Evolving Approaches in Diagnosis and Management

Looking beyond ANA as an entry criterion for the classification of SLE

Diagnostic performance of particle-based multi-analyte technology (PMAT) compared to indirect immunofluorescence (IFA) in screening for ANA in patients with autoimmune rheumatic diseases

The potential role of the likelihood ratio approach to support diagnosis and classification of Autoimmune Diseases

International Consensus on Antinuclear Antibody Patterns (ICAP) 2025: what’s new?

Helicobacter pylori infection as a trigger of ANA

Inflammatory Bowel Disease in Lithuania: Epidemiology, Immunological Insights, and Diagnostic Approaches

Multi analyte testing in autoimmunity: From early days to modern technologies

Clinical strategies for the effective diagnosis and management of myositis

Predicting progression from undifferentiated connective tissue disease to clinically overt disease using particle-based multi-analyte technology

Italian guidelines for the immunological diagnosis of autoimmune liver diseases: a step forward from EASL guidelines

Circulating Calprotectin (cCLP) in autoimmune diseases

Biomarkers as tools for Precision Medicine in Rheumatoid Arthritis

It is time to revise RA classification by changing RF and ACPA scores

How novel technologies improve the diagnosis of celiac disease

Clinical Validity of Anti-Proteinase 3 Antibodies in Patients with Inflammatory Bowel Disease

Primary biliary cholangitis: the disease of 100 autoantibodies

Acute Care Expert Meeting

Optimizing Point-of-Care Testing: Key Strategies for Ensuring High-Quality Results

Reducing Sample Quality Errors in POC Blood Gas Testing

The Hidden Impact of Preanalyticson Point-of-Care Testing Accuracy

Experience Sharing: POC Organizational Models in the world

Implementing Connectivity Solutions in Point of Care Testing Accuracy

Oversight and Management of POCT in a Large Health Institution

Meeting Regulatory and Accreditation Standards for POCT in Poland

Patient Blood Management: Evidence-based Impact on Mortality Reduction

Implementation of Patient Blood Management in Clinical Practice

Optimizing Patient Safety Through Comprehensive Bleeding Management In Cardiac Surgery

Heparin monitoring during cardio pulmonary bypass

Trauma-induced Coagulopathy: Patient Blood Management vs Shock Packages

The management of hemostasis and thrombosis in traumatic brain injury

Goal-DirectedMassiveBleedingManagementPrinciplesinthePerioperativeSetting.

Bleeding Management in Post Surgical Complications and Cases Discussion

Immunogenetics Seminar

Immunophenotype and immunogenetic profiles in females with reproductive failure

A Single Centre Experience of HLA Typing by TGS Using NanoTYPE assays

Shaping the Next Generation of MATCH IT!® Software

Getting to Grips with Non-HLA antibody

Full automation for the HLA antibody test: The Florence Experience

Charting the Future of HLA Typing with the Next-Gen Sequencer

The role of memory B cells in Kidney Transplantation: Relevance, Risk and Research

Transfusion Seminar

Challenges and everyday life in immunohematology laboratories: Case Studies

Changes in isoagglutinin titers and their clinical significance

Identification of the multiple combinations of antibodies to red blood cells

FNAITP Uncovered: Diagnostic and Transfusion Strategies Through the Lens of a Clinical Case

The Role of Molecular Biology and Genotyping in Enhancing Immunohematology Practices

Platelet Transfusion Refractoriness: Clinical Significance and Laboratory Diagnostics

POSSIBILITY OF WEAK D ANTIGENDETECTION USING THE “SOLID PHASE” TECHNIQUE ON THE NEO IRIS AUTOMATEDSYSTEM

Redefining immunohematology: a technological journey toward diagnostic excellence

RhD Complexity and clinical relevance

For More Information

Raffaella Airaghi ->+39 3442923075, mail: rairaghi@werfen.com

Manuela Bernasconi ->+39 347 2841488, mail: mbernasconi@werfen.com

Loreta Mihaj -> +39 3499354416, mail: lmihaj@werfen.com